Intracrine oestrogen production and action in breast cancer: an epigenetic focus

Kevin C Knower1, Sarah Q To, Colin D Clyne

  • 1Cancer Drug Discovery, Prince Henry's Institute, Clayton, Victoria, Australia.

Insights

Epigenetic modifications influence oestrogen receptor-positive breast cancer development and endocrine therapy resistance. Targeting these reversible epigenetic changes offers promising therapeutic strategies for breast cancer treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Endocrinology

Background:

  • Epigenome alterations are implicated in breast cancer initiation and progression.
  • Endocrine therapies are effective for oestrogen receptor-positive (ER+) breast cancer, especially in postmenopausal women.
  • Therapy resistance is a significant clinical challenge in ER+ breast cancer management.

Purpose of the Study:

  • To review the role of epigenetics in oestrogen-dependent breast cancer.
  • To discuss the influence of epigenetics on intracrine oestrogen production and oestrogen action.
  • To explore the connection between epigenetics and endocrine resistance, and current epigenetic therapies.

Main Methods:

  • Literature review focusing on epigenetics in breast cancer.
  • Analysis of studies on oestrogen metabolism and epigenetic regulation.
  • Examination of research on epigenetic mechanisms driving endocrine resistance.

Main Results:

  • Epigenetic modifications impact intracrine oestrogen production in postmenopausal women.
  • Oestrogen signaling influences epigenetic processes within breast cancer cells.
  • Epigenetic alterations are linked to the development of resistance to endocrine therapies.

Conclusions:

  • Epigenetics plays a critical role in oestrogen-dependent breast cancer and endocrine resistance.
  • Reversible epigenetic modifications present viable targets for novel breast cancer therapies.
  • Advancements in epigenetic therapy offer new avenues for overcoming endocrine resistance in breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...